| pubmed-article:2644876 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2644876 | lifeskim:mentions | umls-concept:C0022616 | lld:lifeskim |
| pubmed-article:2644876 | lifeskim:mentions | umls-concept:C0028066 | lld:lifeskim |
| pubmed-article:2644876 | lifeskim:mentions | umls-concept:C0034735 | lld:lifeskim |
| pubmed-article:2644876 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:2644876 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:2644876 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2644876 | pubmed:dateCreated | 1989-3-17 | lld:pubmed |
| pubmed-article:2644876 | pubmed:abstractText | Twenty-eight patients suffering from either primary or secondary Raynaud's phenomenon were treated with nifedipine and ketanserin. Each patient was treated with one of the two drugs administered after an adequate washout period. Furthermore each patient was submitted before and after treatment with each drug to computerized digital thermometry to evaluate the therapeutic response. The data obtained during the intake of the two drugs at zero, five, and twenty-three minutes were compared with thermometry-relevant baseline data at the same periods. Ketanserin proved to be useful in the treatment of Raynaud's phenomenon and statistically significantly superior (alpha less than 0.05) with respect to nifedipine in the thermometric controls and also in the subjective evaluation of the patients (p less than 0.02). In this study nifedipine did not show particular efficacy. Furthermore only 2 patients had to discontinue treatment with ketanserin, whereas 8 had to discontinue treatment with nifedipine (p less than 0.001). | lld:pubmed |
| pubmed-article:2644876 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2644876 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2644876 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2644876 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2644876 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2644876 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2644876 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:2644876 | pubmed:issn | 0003-3197 | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:De SandreGG | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:CorrocherRR | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:PerbelliniAA | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:BambaraL MLM | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:PerbelliniLL | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:OlivieriOO | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:CaramaschiPP | lld:pubmed |
| pubmed-article:2644876 | pubmed:author | pubmed-author:CodellaOO | lld:pubmed |
| pubmed-article:2644876 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2644876 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:2644876 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2644876 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2644876 | pubmed:pagination | 114-21 | lld:pubmed |
| pubmed-article:2644876 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:meshHeading | pubmed-meshheading:2644876-... | lld:pubmed |
| pubmed-article:2644876 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2644876 | pubmed:articleTitle | Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon. | lld:pubmed |
| pubmed-article:2644876 | pubmed:affiliation | Università degli Studi di Verona, Italy. | lld:pubmed |
| pubmed-article:2644876 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2644876 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2644876 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2644876 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
